Idenix Pharmaceuticals (IDIX)

4.07 +0.01  +0.25%  May 21, 5:00PM
Add to Watchlists Create an Alert

Idenix Pharmaceuticals SG&A Expense Quarterly:

7.535M for March 31, 2013
View Full Chart

Idenix Pharmaceuticals SG&A Expense Quarterly Chart

    Idenix Pharmaceuticals Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 7.535M
    Dec. 31, 2012 7.365M
    Sept. 30, 2012 6.164M
    June 30, 2012 5.861M
    March 31, 2012 4.774M
    Dec. 31, 2011 4.401M
    Sept. 30, 2011 3.90M
    June 30, 2011 4.48M
    March 31, 2011 3.914M
    Dec. 31, 2010 9.131M
    Sept. 30, 2010 4.44M
    June 30, 2010 5.091M
    March 31, 2010 4.777M
    Dec. 31, 2009 4.888M
    Sept. 30, 2009 5.207M
    June 30, 2009 5.357M
    March 31, 2009 6.016M
    Dec. 31, 2008 5.702M
    Sept. 30, 2008 6.457M
       
    June 30, 2008 6.651M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    IDIX SG&A Expense Quarterly Benchmarks

    Companies
    Achillion Pharmaceuticals 3.074M
    Vertex Pharmaceuticals 92.88M
    Peregrine Pharmaceuticals 3.112M

    IDIX SG&A Expense Quarterly Rankings

    Overall 61st percentile
    3115 of 8002
    Sector 58th percentile
    281 of 684 in Healthcare
    Industry 75th percentile
    60 of 248 in Biotechnology

    IDIX SG&A Expense Quarterly Range, Past 5 Years

    Minimum 3.900M Sep 2011
    Maximum 9.131M Dec 2010
    Average 5.606M